Engineers Gate Manager’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$384K Buy
110,348
+49,858
+82% +$190K ﹤0.01% 1566
2025
Q4
$210K Buy
60,490
+4,893
+9% +$21.8K ﹤0.01% 1784
2025
Q3
$308K Buy
+55,597
New +$226K ﹤0.01% 1738

Other funds holding PRME

Engineers Gate Manager's PRME Position: Q1 2026 in Review

Engineers Gate Manager increased its Prime Medicine (PRME) stake by 82% in Q1 2026, buying an estimated $190K and bringing the position to 110,348 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #1566.

Engineers Gate Manager first reported a position in PRME in Q3 2025 and has held it in 3 quarters since. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Engineers Gate Manager held 110,348 shares of Prime Medicine worth $384K as of Q1 2026.
  • Engineers Gate Manager bought 49,858 Prime Medicine shares in Q1 2026, an estimated $190K.
  • Prime Medicine made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1566 holding.
  • Engineers Gate Manager first reported a position in Prime Medicine in Q3 2025 and has held it in 3 quarters since.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.